Heart Test Valuation
| HSCS Stock | USD 2.91 0.01 0.34% |
Based on Macroaxis valuation methodology, the firm appears to be undervalued. Heart Test Laboratories retains a regular Real Value of $5.49 per share. The prevalent price of the firm is $2.91. Our model calculates the value of Heart Test Laboratories from evaluating the firm fundamentals such as return on equity of -1.63, and Return On Asset of -0.63 as well as inspecting its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Heart Test's valuation include:
Price Book 1.7428 | Enterprise Value | Enterprise Value Ebitda (0.14) | Price Sales 202.0661 | Enterprise Value Revenue 46.2621 |
Undervalued
Today
Please note that Heart Test's price fluctuation is slightly risky at this time. Calculation of the real value of Heart Test Laboratories is based on 3 months time horizon. Increasing Heart Test's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Heart stock is determined by what a typical buyer is willing to pay for full or partial control of Heart Test Laboratories. Since Heart Test is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Heart Stock. However, Heart Test's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.91 | Real 5.49 | Target 13.5 | Hype 2.84 | Naive 3.39 |
The intrinsic value of Heart Test's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Heart Test's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Heart Test Laboratories helps investors to forecast how Heart stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Heart Test more accurately as focusing exclusively on Heart Test's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Heart Test's intrinsic value based on its ongoing forecasts of Heart Test's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Heart Test's closest peers.
Heart Test Cash |
|
Heart Valuation Trend
Heart Test's real value is important for investors to make better decisions and a more accurate overall view of Heart Test's financial worth over time. Using both Heart Test's enterprise value as well as its market capitalization is the best way to gauge the value of the company and is usually enough for investors to make market timing conclusions.
Heart Test Total Value Analysis
Heart Test Laboratories is currently forecasted to have valuation of 3.5 M with market capitalization of 3.15 M, debt of 1.04 M, and cash on hands of 4.27 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Heart Test fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
3.5 M | 3.15 M | 1.04 M | 4.27 M |
Heart Test Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Heart Test has an asset utilization ratio of 0.2 percent. This implies that the Company is making $0.001957 for each dollar of assets. An increasing asset utilization means that Heart Test Laboratories is more efficient with each dollar of assets it utilizes for everyday operations.Heart Test Ownership Allocation
Heart Test retains 8.99 (percent) of its outstanding shares held by insiders and 0.15 (percent) owned by outside corporations.Heart Test Profitability Analysis
The company reported the previous year's revenue of 18.6 K. Net Loss for the year was (6.61 M) with profit before overhead, payroll, taxes, and interest of 0.About Heart Test Valuation
The stock valuation mechanism determines Heart Test's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Heart Test Laboratories based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Heart Test. We calculate exposure to Heart Test's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Heart Test's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 11.3 K | 8.6 K | |
| Pretax Profit Margin | (408.39) | (428.81) | |
| Operating Profit Margin | (389.87) | (409.37) | |
| Net Loss | (408.39) | (428.81) | |
| Gross Profit Margin | 0.61 | 0.39 |
Heart Test Growth Indicators
Investing in growth stocks can be very risky. If the company such as Heart Test does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 352.5 K |
Heart Test Current Valuation Indicators
Heart Test's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Heart Test's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Heart Test, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Heart Test's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Heart Test's worth.Additional Tools for Heart Stock Analysis
When running Heart Test's price analysis, check to measure Heart Test's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heart Test is operating at the current time. Most of Heart Test's value examination focuses on studying past and present price action to predict the probability of Heart Test's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heart Test's price. Additionally, you may evaluate how the addition of Heart Test to your portfolios can decrease your overall portfolio volatility.